Dexamethasone Sodium Phosphate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 76420-185
  • Package NDC 76420-185-01
  • Application number ANDA040803
  • SPL ID b4ea9bea-3f7b-4dc9-e053-2a95a90ae557
  • SPL set ID b2ce414a-3b1f-4533-bb3a-18594529dead
  • UNII AI9376Y64P
  • RxCUI 1812194

What the source publishes

Labeler
Asclemed USA, Inc.
Active ingredients
Dexamethasone Sodium Phosphate
Form
INJECTION, SOLUTION
Routes
INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR, INTRAVENOUS, SOFT TISSUE
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:76420-185_b4ea9bea-3f7b-4dc9-e053-2a95a90ae557
{
  "name": "Dexamethasone Sodium Phosphate",
  "splId": "b4ea9bea-3f7b-4dc9-e053-2a95a90ae557",
  "labels": [
    {
      "setId": "b2ce414a-3b1f-4533-bb3a-18594529dead",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2ce414a-3b1f-4533-bb3a-18594529dead",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2ce414a-3b1f-4533-bb3a-18594529dead"
    }
  ],
  "routes": [
    "INTRA-ARTICULAR",
    "INTRALESIONAL",
    "INTRAMUSCULAR",
    "INTRAVENOUS",
    "SOFT TISSUE"
  ],
  "labeler": "Asclemed USA, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 mL in 1 VIAL (76420-185-01)",
      "package_ndc": "76420-185-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20201121"
    }
  ],
  "productId": "76420-185_b4ea9bea-3f7b-4dc9-e053-2a95a90ae557",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "76420-185",
  "deaSchedule": null,
  "genericName": "Dexamethasone Sodium Phosphate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "DEXAMETHASONE SODIUM PHOSPHATE",
      "strength": "4 mg/mL"
    }
  ],
  "applicationNumber": "ANDA040803",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20110511",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "AI9376Y64P"
    ],
    "rxcui": [
      "1812194"
    ],
    "spl_set_id": [
      "b2ce414a-3b1f-4533-bb3a-18594529dead"
    ],
    "manufacturer_name": [
      "Asclemed USA, Inc."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:76420-185_b4ea9bea-3f7b-4dc9-e053-2a95a90ae557"